Status and phase
Conditions
Treatments
About
To investigate the efficacy and safety of Qishenyiqi in patients with microvascular angina pectoris. Long-term follow-up of 1 year will be performed to evaluate the effect of Qishenyiqi on coronary flow reserve and adverse cardiovascular events in patients with coronary microvascular disease.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
162 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Panpan Hao, Dr.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal